Needle-Free Injector

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2605E05] JSKBIOMED Inc. is a biomedical company specializing in laser-based, needle-free injection technology, developing next-generation drug delivery solutions that address the limitations of conventional injection methods ― including pain, infection risk, and medical-waste generation.
Based on proprietary technology that precisely controls the skin barrier using laser energy, the company has established a platform capable of effectively delivering drugs, vaccines, and functional substances, with scalability across medical, aesthetic, and healthcare fields.

Following the stabilization of its core technology in 2025, JSKBIOMED has begun full-scale expansion into overseas markets, entering major countries including Japan, Poland, and Sweden. In Korea, the technology is currently being applied in approximately 300 hospitals and clinics, thereby, demonstrating both technical stability and clinical applicability.
JSKBIOMED recently introduced its laser-based, needle-free injection technology and new product lineup ― aiming to expand strategic partnerships with overseas distributors, medical device companies, and pharmaceutical and biotech firms. The company has been seeking to release collaboration models tailored to country-specific distribution structures and market characteristics while building long-term global networks.
JSKBIOMED’s flagship medical product, MiraJet, utilizes laser-based needle-free injection technology to deliver drugs and active ingredients effectively while minimizing skin damage. It is designed to reduce pain and infection risk while lowering dependency on practitioner skill, thereby enabling a more consistent treatment environment.
JSKBIOMED also recently introduced its aesthetic equipment Jetical Pro 2940, which presents a solution optimized for professional treatment settings. Based on precise laser- control technology, it supports stable energy delivery and enhanced treatment control, and is designed to improve skin condition and increase the efficiency of active ingredient delivery. It can be applied to various skin types and treatment purposes, expanding its usability in professional clinics.

In addition, JSKBIOMED is expanding into the homecare market with the Jetical Mini Pro, a consumer device that integrates the core technology of its medical and professional equipment. Designed with enhanced usability and safety, it enables personalized skincare management, forming an integrated laser-based needle-free injection solution ecosystem across medical, professional, and home-use categories.
JSKBIOMED has identified the United States, Japan, China, France, and Germany as key target markets. These countries represent mature medical and aesthetic device markets with continuously increasing demand for high-performance and high-value aesthetic technologies. The company plans to pursue phased market expansion through collaboration with local buyers, distributors, and global beauty and biotech companies.
In the first half of 2026, JSKBIOMED will be participating in major international exhibitions such as AMWC Monaco and ASLMS in order to strengthen global brand recognition, while promoting its technology and expanding partnerships.
At the same time, JSKBIOMED will pursue country-specific regulatory approvals and certifications in stages and accelerate its growth as a global laser-based needle-free injection platform company through technology licensing, joint development, and diversified collaboration models.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

AI-based Personalized Pelvic-Wellness Platform

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2605E04] MBLab is an innovative technology company that develops solutions to improve women’s quality of life through AI- and data-based digital healthcare technologies. Focusing on women’s pelvic health and wellness (Pelvic Wellness), the company combines medical expertise with user experience to expand its presence in the global Femtech market.
With the vision of understanding women through AI and data, and redefining health in life, MBLab aims to evolve into a personalized health management platform.
MBLab’s core mission is built on scientific, evidence-based technology development, user-centered health experience design, and global market expansion. By utilizing data and AI, the company develops personalized health solutions while incorporating the insights of medical professionals to deliver practical wellness experiences. At the same time, it is accelerating global expansion through overseas distribution and strategic partnerships.

In Korea, MBLab has already supplied its VVP3500 diagnostic device and RT4000 urinary incontinence treatment system to 250 hospitals, where they are actively used in clinical settings.

In Japan, MBLab has exported its AI- and data-based pelvic-health solution Ekegel, thereby establishing a foothold in the market. Through participation in MEDICA 2025 and CES 2026, the company has drawn interest from global buyers, and is advancing its international marketing efforts.
MBLab recently introduced locally not merely a conventional Kegel device, but an AI-based personalized Pelvic Wellness Platform. The solution is structured as an intelligent pelvic floor management system that integrates measurement, analysis, personalized exercise, and feedback. It analyzes contraction, endurance, and relaxation data, incorporates a 12-item vaginal health checklist, classifies users based on AI algorithms, and automatically sets optimal exercise intensity tailored to each individual.
The platform is positioned as a clinically recognized product used in hospitals and medical channels. By going beyond a simple exercise device and providing a data-driven continuous management system, it enhances the precision of women’s health management. It is applicable to various conditions, including urinary incontinence, postpartum recovery, and pelvic health management for middle-aged women.
MBLab aimed at increasing awareness of AI-based pelvic health solutions in the domestic healthcare market, discovering hospital, clinic, and distribution partners, and gathering feedback from medical professionals in order to further refine its products. At the same time, the company seeks to strengthen domestic references to support its global expansion strategy.
MBLab’s global strategy will proceed in three phases: first, establishing a foundation for entry into the North American market; second, expanding in Japan and securing entry opportunities in Europe; and third, targeting premium markets in the Middle East and China.
Following participation in MEDICA 2025 and CES 2026, MBLab plans to attend CES 2027 and healthcare exhibitions in Dubai, while continuing to expand its domestic and international network through participation in future KIMES events.
Through its AI-based personalized pelvic-health management platform, MBLab aims to present a new standard in women’s wellness and strengthen its competitiveness in the global Femtech market as a data-driven technology company.


 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Digital Therapeutics

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Accelerating Global DTx Market Expansion
[INQ. NO. 2605E03] Beyondmedicine Co., Ltd. is an AI-based Digital Therapeutics (DTx) company founded in 2022, developing prescription-based digital treatment solutions focused on chronic and recurrent Temporomandibular Disorder (TMD).
Recognizing that TMJ disorders are difficult to manage through single, clinic-centered treatments alone, Beyondmedicine has introduced its core product, ClicklessDTx, a digital therapeutic designed to improve patients’ daily behavioral correction and treatment adherence.
By integrating Cognitive Behavioral Therapy (CBT) technology, the platform objectively collects and analyzes patients’ rehabilitation exercise performance and symptom changes ― providing an integrated digital-treatment system that enables clinicians to manage treatment progress beyond the clinic.
Through ClicklessDTx, Beyondmedicine conducted the world’s first Randomized Controlled Trial (RCT) targeting temporomandibular disorder patients and published the results in the SCI-indexed international Journal of Dentistry, thereby demonstrating its clinical efficacy.

It also obtained designation as an Innovative Medical Device from the Korean Ministry of Food and Drug Safety (MFDS), becoming the first digital therapeutic device in the dental field to receive such recognition in Korea. The company has completed domestic medical device approval for its TMJ digital therapeutic device. Overseas, it completed the U.S. FDA Pre-submission process and received recognition as a Novel Technology, thus securing a foundation for global regulatory approval.
Beyondmedicine recently presented a hospital-prescription-based digital-treatment model centered on ClicklessDTx. It emphasized that the solution can operate in conjunction with conventional physical therapy, thereby simultaneously improving hospital-treatment efficiency and revenue structure. Locally, it showcased real clinical data and a clinician-exclusive dashboard to explain product differentiation and practical application, while seeking early-adopter medical institutions and global partners.

ClicklessDTx is a prescription-based digital-treatment system integrating into a single platform home-based rehabilitation, behavior modification, symptom tracking, treatment feedback, and clinical reporting. Patients perform therapeutic programs in daily life while accumulating data, and clinicians can systematically monitor treatment progress and adherence outside the hospital through a dedicated clinician dashboard. The system is designed to complement the limitations of episodic treatment and enhance treatment continuity and management efficiency.
Users are expected to achieve clinically validated improvements through 5–10 minutes of daily program participation over six weeks. The treatment process is visualized through data-based interfaces, allowing both patients and clinicians to intuitively track therapeutic changes.
Beyondmedicine has identified the United States, Japan, and major European countries as key target markets. The United States represents a high-acceptance market with an established regulatory framework for digital therapeutics, and the company is pursuing initial entry based on FDA approval procedures. Japan faces increasing demand for chronic pain and rehabilitation solutions due to population aging, while Europe’s evidence-based healthcare system provides a favorable environment for RCT-based digital therapeutic adoption.
Going forward, Beyondmedicine plans to advance full-scale commercialization of ClicklessDTx in Korean hospitals and gradually expand global market entry in accordance with U.S. FDA regulatory processes. The company will also strengthen global partnerships through participation in international dental and digital health exhibitions and conferences, while expanding its pipeline beyond TMJ digital therapeutics into facial paralysis rehabilitation and broader dental and oral healthcare areas. To support this expansion, the company is preparing for Series-A investment fundraising.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Photorealistic 3D Avatar-Based Body-Analysis Solution

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2605E02] VBody was founded by the Yonsei University Computer Graphics Lab to address the subjectivity of body-shape assessments and the inconsistencies in tracking physical changes that frequently occur in fitness centers, Pilates studios, and clinics.
Traditional visual assessments and 2D photo-based consultations often vary, depending on the evaluator, resulting in inconsistent explanations and reduced persuasiveness when presenting before-and-after results. Leveraging computer-vision and 3D neural rendering-based human digitization technology, VBody has commercialized a solution that generates photorealistic 3D avatars and standardized body metrics from a simple capture process, enabling not just ‘visible change’ but also ‘measurable and explainable change.’
Since its official launch in December 2025, VBody has established a nationwide sales and supply system, offering packaged solutions that combine 3D scanning hardware and AI-powered body-analysis software to B2B clients including fitness centers, Pilates studios, and clinics. On-site workflows ― from capture, to 3D avatar generation, body metric calculation, and before-and-after comparison reporting ― have been standardized to minimize operational burdens.
VBody recently introduced its technology locally, as a solution capable of simultaneously achieving objective body and posture evaluation and enhanced patient communication in medical and healthcare settings. The company emphasizes that its photorealistic 3D avatars and AI-based analytical metrics generated from brief capture sessions can shorten consultation times, while presenting treatment and exercise outcomes according to consistent standards.
VBody’s body-analysis and change-tracking solution enhances consultation persuasiveness through 3D visualization and provides AI-based standardized metrics, ensuring consistent evaluation, explanation, and tracking regardless of practitioner or branch location. Objective data is delivered by posture estimation-based key-point analysis, joint and trunk-angle measurements, and proportional indicators ― while accumulated longitudinal data and before-and-after comparison reports intuitively demonstrate treatment and exercise outcomes. This approach has attracted industry interest for its potential to support re-visits and re-registration performance.

VBody has identified the United States, Japan, and the Middle East as priority overseas markets. The United States represents a rapidly expanding market for digital health and data-driven fitness consultations. Japan, facing rapid aging, has strong demand for rehabilitation and posture correction and a high acceptance of standardized reporting. The Middle East is characterized by active investment in premium healthcare and fitness infrastructure, with growing interest in advanced equipment that enhances customer experience.
Looking ahead, VBody plans to expand nationwide distribution in 2026, while establishing a partnership framework capable of supporting repeat adoption. The company is preparing for global expansion with a target of participating in CES 2027. Based on domestic field references, VBody aims to further refine product completeness and establish a new standard for 3D-based body digitization in the global healthcare and fitness markets.

 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

AI-Based Smartwatch

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Targeting Both Industrial Safety and Elderly Care
[INQ. NO. 2605E01] Innomes is a technology company providing smart healthcare solutions designed to protect workers in industrial environments and vulnerable populations in densely populated settings.
Centered on its AI-powered smartwatch InnoCare System, Innomes is expanding simultaneously into industrial safety and elderly healthcare markets through an IoT smartwatch equipped with multi-sensor technology.
The InnoCare System collects and analyzes real-time biometric data via nine embedded sensors in the smartwatch, including heart rate and body temperature. The system is designed to detect early-warning signs of heatstroke, overexertion, and cardiac abnormalities ― particularly in high-temperature, high-humidity, or physically demanding work environments. Data is transmitted in real time to an AI-based integrated monitoring platform, where abnormal patterns trigger immediate alerts to administrators, thereby assisting in the prevention of serious industrial accidents.

Innomes successfully developed its safety and health management system for major accident prevention through the Ministry of SMEs and Startups’ Smart Manufacturing Innovation R&D Program. The solution has been supplied to small and medium-sized manufacturers in the Changwon National Industrial Complex and to Changwon Leports Park, thereby establishing domestic reference cases. Building on this foundation, the company signed MOUs with Thai manufacturing firms AOSSAWIN and SETTHAMOUSHOL in Bangkok through the Gyeongnam Changwon Defense Innovation Cluster overseas export support program, and is currently advancing discussions.
Innomes recently locally presented the InnoCare System as a first step toward establishing a safety and health management system under the Serious Accidents Punishment Act. Beyond industrial sites, the company will emphasize its scalability as a real-time health monitoring solution for elderly individuals living alone, and populations vulnerable to heat-related illnesses.
Through its administrator-mode integrated monitoring dashboard, the system enables comprehensive data analysis across worksites and supports AI-based predictive risk management.
Innomes has identified Thailand and Japan as key target markets for overseas expansion. Thailand is experiencing increasing smartwatch adoption and demographic aging, creating growing demand from elderly care facilities, hospitals, and healthcare institutions.
The company is pursuing collaboration with local medical firm Chalerm Prakarn Group and exploring potential partnerships with Bangkok Hospital and global medical tourism platforms.
Japan, one of the world’s most rapidly aging societies, presents strong demand for elderly health and safety management solutions. Innomes is preparing for market entry through a partnership with Omron Corporation and is strengthening localization strategies by collaborating with AI-based personalized care solution providers.
Starting in 2026, Innomes plans to participate sequentially in major domestic and international exhibitions including MEDICA, Medical Fair Asia, etc. Through these platforms, the company aims to expand its global buyer and partner network, establish regulatory and certification strategies for local markets, and accelerate overseas market entry aligned with customized product development.
By integrating industrial safety and elderly healthcare into a unified framework, Innomes seeks to build a data-driven preventive healthcare ecosystem powered by AI-based biometric monitoring technology.

 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Korea’s Exporters

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Korea’s Exporters Continuing Astounding Growth

Releasing Globally Competitive New Items

Korea’s exports have broken all-time records for the month of April, boosted by the global expansion of artificial intelligence (AI) infrastructure.
The nation’s exports in April recorded $85.89 billion, a 48.0% increase compared to the same month last year. Imports rose by 16.7% to $62.11 billion, resulting in a surplus of $23.77 billion in trade balance. With this, Korea set a record by surpassing $80 billion in exports and $20 billion in trade balance for the first time in history.

The undisputed star contributor was semiconductors. As global investment in AI infrastructure expanded, massive demand emerged for both NAND and DRAM, causing semiconductor exports to surge by a staggering 173.5% year-on-year to reach $31.9 billion. This marks the highest monthly record for the 13th consecutive month. The computer (SSD) sector also showed growth, increasing by 515.8% due to an explosion in demand for data centers driven by the spread of AI.

Korea’s Competitive New Items Attracting Keen Attention of Potential Buyers
Korean companies are ceaselessly launching new products. Striving to achieve their export performance goals for this year, creative efforts are being made to engage in the development of competitive products.
VBody recently introduced its technology locally, as a solution capable of simultaneously achieving objective body and posture evaluation and enhanced patient communication in medical and healthcare settings. The company emphasizes that photorealistic 3D avatars and AI-based analytical metrics generated from brief capture sessions can shorten consultation times, while presenting treatment and exercise outcomes according to consistent standards.

MBLab recently introduced locally not merely a conventional Kegel device, but an AI-based personalized Pelvic Wellness Platform. The solution is structured as an intelligent pelvic floor management system that integrates measurement, analysis, personalized exercise, and feedback. It analyzes contraction, endurance, and relaxation data, incorporates a 12-item vaginal health checklist, classifies users based on AI algorithms, and automatically sets optimal exercise intensity tailored to each individual.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

SK on Co.

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

SK on Co. Targeting Japan with its Vehicle Batteries

Aiming to receive orders for ESS to expand business

SK on Co., the battery affiliate of SK Group, is set to open a branch in Japan to target the local market. According to industry sources, SK on has been proceeding with administrative procedures with the goal of establishing a branch in Tokyo, Japan, and is actually in the final stage.
SK on’s decision to open a branch in Tokyo is regarded not merely as an expansion of its overseas presence, but as a direct challenge to capture Japan’s key and traditionally conservative automotive market.

According to the Nekkei, Japan’s passenger EV sales reached 26,959 units from January to March this year, up 80% compared to the same period last year. This marks a record high for a single quarter.
Japanese automakers are known for their stringent standards on quality and safety, making the market difficult to enter. However, once a deal is secured, it often evolves into a long-term partnership ― meaning that early entry can significantly impact medium- to long-term performance.
SK on has already achieved tangible orders in Japan. Last year, it signed a battery-supply agreement with Nissan Motor Co., demonstrating its technological capabilities.
SK on has already established sales bases in major markets including the USA, Germany, and China. It also set up a North American regional headquarters (RHQ) in Detroit, Michigan, last year to strengthen local operations. With Japan added, its global network across key automotive markets is nearing completion.

  
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Industry News Tagged With:

Samsung Electro-Mechanics

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Samsung Electro-Mechanics Invests KRW 1.8 Tril. in Vietnam

Responding to surging demand for AI substrates
Orders from big-tech companies expected to increase

Samsung Electro-Mechanics plans to invest KRW 1 trillion in its Vietnam production base to expand the production of semiconductor substrates, aiming to resolve production-capacity limitations and enhance supply responsiveness amidst the rapidly increasing demand for high-value-added substrates for artificial intelligence (AI).
According to Bloomberg, the company will invest US$ 1.2 billion (approximately KRW 1.8 trillion) to expand production facilities for flip-chip ball greed array (FC-BGA photo) at its Vietnam production base. It has also completed investment registration procedures with the Vietnam Foreign Investment Agency for AI-related FC-BGA production.

This investment is reported as a strategy to restructure its existing production base to focus on high-value-added substrates. FC-BGA is a high-density package substrate in which semiconductor chips are mounted upside down on a substrate and connected by using fine metal balls.
The scale of this investment is comparable to the company’s initial entry into Vietnam in 2013 when it constructed a camera-module and printed circuit board (PCB) plant. This is a trillion-dollar investment made again after 13 years.
It customer base is also expanding quickly. Samsung Electro-Mechanics is supplying substrates to global tech firms such as Broadcom, Google, and Amazon.

The company recently secured a deal to supply FC-BGA to Grock 3 language processing unit (LPU), a dedicated inference chip installed in Nvidia’s next-generation AI semiconductor Vera Rubin, with mass-production expected to begin in the second quarter of this year.
There is also growing speculation that its FC-BGA could be adopted for Tesla’s AI chip, the AI6, signaling further expansion of its big-tech client base.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Industry News Tagged With:

Samsung and LG Collaborate on Gaming Monitors

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Joining hands in targeting this high-value market against China

Samsung and LG, which have long completed against each other in Korean and global home appliance markets, set in motion an effort to cooperate. According to industry sources, Samsung Electronics Co. has decided to use white (W)-OLED panels made by LG Display Co. in its upcoming OLED gaming monitor, Odyssey G7, set for release this year. This follows LG Electronics Inc.’s decision to adopt quantum dot organic light-emitting diode (AD-OLED) panels from Samsung Display Co. in its gaming monitors scheduled for release in the second half of this year.

It is reported that Samsung Electronics Co. has selected panels from LG Display Co. to expand to OLED its Odyssey G7 monitor lineup, which was originally released last year using LCDs. With reports indicating that Samsung Electronics Co. and LG Display Co. have signed a panel supply contract and commenced full-scale mass-production and set manufacturing early this year. Forecasts suggest it is highly likely to launch in the second quarter of this year.
This collaboration between Samsung and LG is seen as a strategy to counter China, which has emerged as a new threat by leveraging cost-effectiveness and technological advancement.
Demand for gaming monitors in the global market has been increasing every year. Market research firm Omdia forecasts that gaming monitors will account for approximately 35% of total global monitor shipments this year. Also, it is expected that the share of gaming monitor shipments will rise to about 40% by 2029.
In particular, OLED gaming monitors are expected to overtake LCD monitors, which have been the mainstream until now, and establish themselves as the ‘new trend.’ In fact, the revenue share of OLED monitors, which stood at just 1.2% in the total global monitor market in 2022, has expanded to 7.4% in 2023, 13.6% in 2024, and reached 20% last year.
OLEDs are rising in the gaming monitor industry due to their high scan rate and response speed. OLEDs have a self-lighting structure where each individual pixel produces its own light, so they do not have the chronic problems of LCDs ― which include blacklight bleeding, slow response time, and blacklight issues (the phenomenon where black appears gray in dark scenes) ― providing overwhelming contrast ratios and vivid images that appear just like what users see with their own eyes.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Industry News Tagged With:

AI semiconductors and glass substrates

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Glass Substrates with Enhanced Power Efficiency Become a Game Changer for AI Semiconductors

Samsung Electro-Mechanics moves to dominate the glass substrate market.

The competition in semiconductor performance is shifting beyond chips to substrates, due to the rapid expansion of artificial intelligence (AI). As data-processing volumes surge, the role of substrates connecting chips has become increasingly critical. Limitations of conventional plastic-based substrates are becoming more evident, positioning glass substrates as an alternative for high-performance applications.
AI semiconductors, in particular, have a structure tightly linking graphic processing units (GPUs) and high bandwidth memory (HBM).

Plastic (organic) substrates that have been widely used so far are increasingly facing structural limitations due to the large-scale, high-performance trends of AI semiconductors. They are more vulnerable to heat, prone to warping at high temperatures, and require additional layers to enhance performance.
Amidst such expectations and limitations, competition in glass substrates is intensifying. SKC’s subsidiary Absolics is considered closest to commercialization, producing prototypes at its Georgia facility in the USA and conducting tests with global clients. LG Innotek is also preparing for mass-production in 2027-2028, based on its pilot production system.

Global companies are joining the race. Intel is seeking to lead the way in technical conversion by significantly expanding substrate size, while China’s BOE is building supply chains through pilot production lines. Japan’s Ibiden is also advancing development, leveraging its leading position in the substrate market.
Samsung Electronics’ affiliates are likewise moving to strengthen their capabilities in glass substrates based on each affiliate’s core competitiveness and role. Rather than a single unified effort, each affiliate is developing technologies that collectively enhance the group’s packaging competitiveness. Samsung Electro-Mechanics is responsible for developing and mass-producing glass substrates. The company is producing prototypes based on a pilot line in its Sejong Plant, and working with Japan’s Sumitomo Chemical Group to secure a supply chain for glass core materials. The company aims to enter mass production after 2027.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Industry News Tagged With: ,
«Previous Page
Next Page»